Yasmine Iddir

7PUBLICATIONS
163CO-AUTHORS
Molecular targetsLiquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|May 24, 2024
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy.

Charles Bobin, Yasmine Iddir, Charlotte Butterworth

|Jul 14, 2023
Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors.

Mathieu Chicard, Yasmine Iddir, Julien Masliah Planchon

|Jan 18, 2023
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.

Nathalie S M Lak, Lieke M J van Zogchel, Lily Zappeij-Kannegieter

|Jan 05, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.

Elizabeth R Tucker, Irene Jiménez, Lindi Chen

|Oct 20, 2022
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Olivia Ruhen, Nathalie S M Lak, Janine Stutterheim

Pageof 2

Frequent Collaborators

6 joint publications

Gudrun Schleiermacher

4 joint publications

Gaelle Pierron

4 joint publications

Birgit Geoerger

4 joint publications

Alexandra Saint-Charles